The Director of RWE-HO Japan leads the local evidence strategy for GSK's innovative medicines and vaccines, ensuring real-world clinical, economic, and humanistic evidence supports regulatory, reimbursement, and patient access objectives in Japan.
Requirements
- Advanced degree in science, epidemiology, health economics, public health, biostatistics, or related discipline.
- 8+ years of experience in RWE, HEOR, or Market Access within Japan’s pharmaceutical, biotech, or consulting environment.
- Knowledgeable of Japan’s HTA system, Chuikyo processes, and healthcare policy landscape.
- Proven experience designing and delivering impactful RWE/HEOR projects in Japan (regional/global experience a plus).
- Track record of team leadership, coaching, and talent development.
- Business-level Japanese and English proficiency.
- Strategic mindset with strong communication and collaboration skills.
Benefits
- Opportunity to work with a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
- Chance to positively impact the health of 2.5 billion people by the end of the decade as a successful, growing company where people can thrive.
- Inclusive workplace and equal opportunities for all applicants.
- Agile working culture across roles.
- Opportunities for career growth and development.